BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

InViragen 



Fort Collins  Colorado    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





 Company News
Takeda Pharmaceutical Co. Ltd. (TKPYY) Snaps Up InViragen for Up to $250 Million 5/8/2013 7:20:18 AM    More...
InViragen Advances DENVax into Second Stage of Ongoing Phase 2 Clinical Study 2/27/2013 11:07:23 AM    More...
VABIOTECH Licenses Cell-Based Japanese Encephalitis Technology From InViragen 1/3/2013 11:23:22 AM    More...
InViragen and the International Vaccine Institute Expand Partnership 11/8/2012 10:20:09 AM    More...
InViragen to Participate in Biotechnology Industry Organization (BIO) Ventures for Global Health Press Briefing June 18 6/14/2012 10:23:07 AM    More...
InViragen Hand, Foot and Mouth Disease Vaccine Generates Immune Responses in 100% of Study Participants 3/12/2012 8:03:29 AM    More...
InViragen Enlists Advanced BioScience Laboratories, Inc. for Manufacture of Master Virus Seed Stock for Plague Vaccine Development 2/8/2012 7:24:05 AM    More...
InViragen Presents Safety and Immune Response Data from a Phase 1 Study of its Two-Dose Dengue Vaccine, DENVax 12/7/2011 7:14:20 AM    More...
InViragen Initiates a Phase 2 Clinical Study of DENVax, a Recombinant, Tetravalent Dengue Vaccine 11/28/2011 10:47:47 AM    More...
InViragen and University of Texas Medical School Receive Funding for Development of a Novel Recombinant Chikungunya Virus Vaccine 8/16/2011 8:53:51 AM    More...
123

//-->